Targeted therapies and the treatment of non-clear cell renal cell carcinoma
about
Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: current practice and recommendations for improvementSEOM clinical guidelines for the treatment of renal cell carcinoma.PD-L1 expression in nonclear-cell renal cell carcinoma.Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma.Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial.Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma.Characterization of pomiferin triacetate as a novel mTOR and translation inhibitorPathology, therapy and prognosis of papillary renal carcinoma.Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions.Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation.Adjuvant therapy for high-risk localized kidney cancer- emerging evidence and future clinical trials.Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation.Immune checkpoint inhibitors in renal cell carcinoma.Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome.Morphological spectrum of renal cell carcinoma, unclassified: an analysis of 136 cases.
P2860
Q26801279-8C7CD925-9050-4DE2-AF57-4E94A37B6D77Q34553411-AC462C1D-89B8-477F-8B8A-267DC85A28EBQ34882798-57D5C56E-F4FE-4A88-A505-8A7746304E59Q35074682-33CA0E6D-13D9-44B8-A5E6-9B77E32FB70DQ35810625-2259F2CA-8F72-4731-B884-F275391384E6Q36932702-960F302D-D8C7-4928-9EEF-213CD85B1016Q37414808-1EA21150-D4DA-4E90-923A-1F5F5CE1BCEAQ37689248-9A3EAB34-4AB0-4BD9-A64A-B354C59B4AAEQ38312048-47412D75-DED4-4DBB-8473-485022E4A8E8Q38647604-535C549C-00B3-48C2-96E5-089351EA9343Q38673512-596FF8DB-2C8A-407E-9DE0-0876BF501380Q38686841-DE1474B7-3BAB-4EC8-809F-667024C6BC7BQ47116036-BA47D6C0-ED8C-45FB-8198-161F4C34477EQ47592718-E38EB3C1-C83D-4E40-A7EF-53508347AFF8Q47614399-416ACD79-CBD3-4533-98DA-477CC10367E2Q48192906-B276E527-2E7C-4D72-952B-24853EE03020
P2860
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
@ast
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
@en
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
@nl
type
label
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
@ast
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
@en
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
@nl
prefLabel
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
@ast
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
@en
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
@nl
P2860
P3181
P356
P1433
P1476
Targeted therapies and the treatment of non-clear cell renal cell carcinoma
@en
P2093
J. Bellmunt
J. Dutcher
P2860
P304
P3181
P356
10.1093/ANNONC/MDT152
P407
P577
2013-07-01T00:00:00Z